Cargando…
The Quantification of Spike Proteins in the Inactivated SARS-CoV-2 Vaccines of the Prototype, Delta, and Omicron Variants by LC–MS
Developing variant vaccines or multivalent vaccines is a feasible way to address the epidemic as the SARS-CoV-2 variants of concern (VOCs) posed an increased risk to global public health. The spike protein of the SARS-CoV-2 virus was usually used as the main antigen in many types of vaccines to prod...
Autores principales: | Xu, Kangwei, Sun, Huang, Wang, Kaiqin, Quan, Yaru, Qiao, Zhizhong, Hu, Yaling, Li, Changgui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224489/ https://www.ncbi.nlm.nih.gov/pubmed/37243106 http://dx.doi.org/10.3390/vaccines11051002 |
Ejemplares similares
-
LC-MS/MS Quantification of Nevirapine and Its Metabolites in Hair for Assessing Long-Term Adherence
por: Yang, Haoran, et al.
Publicado: (2020) -
Vaccination with Omicron Inactivated Vaccine in Pre-vaccinated Mice Protects against SARS-CoV-2 Prototype and Omicron Variants
por: Zhang, Yuntao, et al.
Publicado: (2022) -
Stoichiometric Quantification of Akt Phosphorylation Using LC-MS/MS
por: Atrih, Abdelmadjid, et al.
Publicado: (2009) -
Pipelines and Systems for Threshold-Avoiding Quantification
of LC–MS/MS Data
por: Sánchez Brotons, Alejandro, et al.
Publicado: (2021) -
Estimation of measurement uncertainty for the quantification of protein by ID-LC–MS/MS
por: Beasley-Green, Ashley, et al.
Publicado: (2023)